Common experiences: Essentially no GI side effects Steady appetite control Weight loss slowing as plateau approaches Improved metabolic markers (blood pressure, cholesterol, blood sugar) Weight loss: Typically 22-27% cumulative by week 48 Management priority: Plan for long-term maintenance
Incretin mimetics, or GLP-1 receptor agonists, are a class of medications used to treat type 2 diabetes (off-label for type 1)
NACET (but not NAC n acetyl cysteine) was able to significantly increase the glutathione content of cells in recent studies PRODUCED AND TESTED IN THE USA: This supplement is manufactured in a GMP and FDA-registered Food-Grade facility
[2] The medication is administered as a once-weekly subcutaneous injection, with doses gradually titrated from 0.25 mg up to a maintenance dose of 2.4 mg over approximately 16 to 20 weeks
Individuals with known hypersensitivity to glutathione or any of the components of the suppositories should avoid use
Your blood sugars lower, and your digestive system slows down (gastroparesis)
